Insider Transactions in Q4 2021 at Pfizer Inc (PFE)
Insider Transaction List (Q4 2021)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Dec 17
2021
|
Albert Bourla Chairman & CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
123,055
+21.55%
|
$3,199,430
$26.47 P/Share
|
|
Dec 17
2021
|
Mikael Dolsten President R&D |
BUY
Exercise of conversion of derivative security
|
Direct |
71,187
+16.84%
|
$2,135,610
$30.17 P/Share
|
|
Dec 03
2021
|
Rady A Johnson Executive Vice President |
SELL
Open market or private sale
|
Direct |
19,000
-2.6%
|
$1,007,000
$53.44 P/Share
|
|
Dec 02
2021
|
Alexander R Mackenzie Executive Vice President |
SELL
Open market or private sale
|
Direct |
41,360
-32.15%
|
$2,233,440
$54.26 P/Share
|
|
Nov 26
2021
|
Sally Susman Executive Vice President |
SELL
Open market or private sale
|
Direct |
44,308
-2.68%
|
$2,392,632
$54.52 P/Share
|
|
Nov 26
2021
|
Douglas M Lankler Executive Vice President |
SELL
Open market or private sale
|
Direct |
40,000
-3.82%
|
$2,160,000
$54.38 P/Share
|
|
Nov 12
2021
|
Angela Hwang President, Global Biopharma |
SELL
Open market or private sale
|
Direct |
26,170
-41.24%
|
$1,282,330
$49.61 P/Share
|
|
Nov 11
2021
|
Mikael Dolsten President R&D |
SELL
Open market or private sale
|
Direct |
59,664
-2.65%
|
$2,983,200
$50.31 P/Share
|
|
Nov 11
2021
|
Mikael Dolsten President R&D |
BUY
Exercise of conversion of derivative security
|
Direct |
199,548
+19.84%
|
$4,988,700
$25.28 P/Share
|
|
Nov 11
2021
|
John D Young Group President |
SELL
Open market or private sale
|
Direct |
150,000
-3.43%
|
$7,500,000
$50.09 P/Share
|